Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2,4 diamino-quinoline as new anticancer agents

Substituted 2,4 diamino-quinoline as new anticancer agents

US Patent 10722505 · Granted Jul 28, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and 2022
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and 2022
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and 2022
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and 2022
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Quinolines derivatives as novel anticancer agents2019
Quinolines derivatives as novel anticancer agents2019
Quinolines derivatives as novel anticancer agents2019